A Randomized Phase III Trial Comparing Folfirinox to Gemcitabine in Locally Advanced Pancreatic Carcinoma

NCT02539537 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

171

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Cancer
Carcinoma

Interventions

DRUG: Gemcitabine
DRUG: Folinic Acid
DRUG: 5-Fluoro-uracil
DRUG: Oxaliplatin
DRUG: Irinotecan
DRUG: L-folinic

Sponsor

UNICANCER